OptiBiotix Health PLC Head of Quality & Operations appointment
08 Octubre 2020 - 1:00AM
RNS Non-Regulatory
TIDMOPTI
OptiBiotix Health PLC
08 October 2020
Opti B i otix Health plc
( "Opti Bi o t ix" or "the Company")
Head of Quality & Operations appointment
OptiBi otix Health p lc (AI M : OPTI), a life sciences busi ness
d e vel o ping co m p o u n ds to tack le o besit y, high choleste
r ol and diabetes announces the appointment of Aneta Zlotkowska as
Head of Quality & Operations.
Aneta joins OptiBiotix from a position as Lead Development
Manager at Tesco Plc, one of the world's largest retailers of
consumer goods where her main responsibilities were within the
distribution business unit in logistics and operations. Prior to
working for Tesco, Aneta was a Quality Assurance and Purchasing
Manager at Cornelius Group Plc where she has also held the
positions of Senior Supply Chain Executive and Supply Chain
Manager. Aneta holds a CIPS Diploma in Procurement and Supply Chain
Management and has completed HACCP and BRC Third Party Auditor
courses by the BRC Academy.
Dr. Fred Narbel , Managing Director of OptiBiotix's prebiotics
division, c o mmented: "Given OptiBiotix's rapid international
expansion with the announcements of various distribution and
manufacturing agreements for SlimBiome(R), OptiBiome(R) and
WellBiome(R) as well as commercial launches of finished products
containing OptiBiotix's technology in the UK (RNS: 7 January 2020)
and the USA & Canada (RNS: 4 May 2020), we feel the need to
appoint a full-time employee with the relevant skillset to manage
and lead OptiBiotix's quality management system and operations.
"Aneta will join the Company on 1 January 2021 and will work
towards ensuring timely deliveries of high-quality ingredients to
OptiBiotix's partners around the world. Moreover, Aneta is tasked
with attaining a BRC certification for OptiBiotix Ltd."
OptiBiotix Health plc www.optibiotix.com
Stephen O'Hara, Chief Executive Contact via Walbrook
below
Walbrook PR Ltd Tel: 020 7933 8780 or optibiotix@walbrookpr.com
Anna Dunphy Mob: 07876 741 001
About OptiBiotix - www.optibiotix.com
OptiBiotix Health plc (AIM: OPTI), which was formed in March
2012, brings science to the development of compounds which modify
the human microbiome - the collective genome of the microbes in the
body - in order to prevent and manage human disease and promote
wellness.
OptiBiotix has an extensive R&D programme working with
leading academics in the development of microbial strains,
compounds, and formulations which are used as active ingredients
and supplements. More than sixty international food and healthcare
supplement companies have signed agreements with OptiBiotix to
incorporate their human microbiome modulators into a wide range of
food products and drinks.
OptiBiotix is also developing its own range of consumer
supplements and health products. The current areas of focus for the
business include obesity, cardiovascular health, diabetes,
digestive health, and health and wellbeing. .
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAMZMGGKNFGGZM
(END) Dow Jones Newswires
October 08, 2020 02:00 ET (06:00 GMT)
Optibiotix Health (LSE:OPTI)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Optibiotix Health (LSE:OPTI)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
